Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

01 September 2007

The Early Detection of Alcohol Consumption (EDAC) test shows better performance than Gamma-glutamyltransferase (GGT) to Detect Heavy Drinking in a large population of males and females

James Harasymiw, Pamela Bean

Med Sci Monit 2007; 13(9): PI19-24 :: ID: 498416

Abstract

Background: This study compared the effectiveness of using the Early Detection of Alcohol Consumption (EDAC) test versus gamma-glutamyltransferase (GGT) to screen for heavy drinking in the general population. Alcohol use was recorded by personal interview; heavy drinking was defined as males drinking 2.5 ounces of alcohol (5 drinks) per day and females drinking 2 ounces (4 drinks) of alcohol daily.
Material/Methods: The population analyzed consisted of 1,022 males (618 heavy drinkers and 404 light drinkers) and 583 females (203 heavy drinkers and 380 light drinkers). The EDAC used 27 routine laboratory tests; a P-positive value >50% was indicative of heavy drinking. The GGT test used a cutoff of 85U/L for males and 65U/L for females.
Results: The results showed that 30% of males reporting heavy drinking tested GGT positive compared to 65% who tested EDAC positive. Specificity was 92% for GGT and 89% for EDAC. Assuming 30% heavy drinking in this population, Positive Predictive Value (PPV) for GGT was 0.62 compared to 0.71 for EDAC. For females, the results showed that 23% of those reporting heavy drinking tested GGT positive compared to 34% who tested EDAC positive. Specificity was 94% for GGT and 98% for the EDAC. PPV for GGT was 0.62 compared to 0.88 for EDAC.
Conclusions: The EDAC test identified twice as many males and 50% more female drinkers than GGT. With higher PPV, the EDAC is a better approach to screen for heavy drinking in both males and females.

Keywords: Alcohol Drinking - blood, Biological Markers, ROC Curve, Time Factors, gamma-Glutamyltransferase - metabolism

Add Comment 0 Comments

Editorial

01 March 2024 : Editorial  

Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and Transfusion-Dependent β-Thalassemia

Dinah V. Parums

DOI: 10.12659/MSM.944204

Med Sci Monit 2024; 30:e944204

0:00

In Press

18 Mar 2024 : Clinical Research  

Sexual Dysfunction in Women After Tibial Fracture: A Retrospective Comparative Study

Med Sci Monit In Press; DOI: 10.12659/MSM.944136  

0:00

21 Feb 2024 : Clinical Research  

Potential Value of HSP90α in Prognosis of Triple-Negative Breast Cancer

Med Sci Monit In Press; DOI: 10.12659/MSM.943049  

22 Feb 2024 : Review article  

Differentiation of Native Vertebral Osteomyelitis: A Comprehensive Review of Imaging Techniques and Future ...

Med Sci Monit In Press; DOI: 10.12659/MSM.943168  

23 Feb 2024 : Clinical Research  

A Study of 60 Patients with Low Back Pain to Compare Outcomes Following Magnetotherapy, Ultrasound, Laser, ...

Med Sci Monit In Press; DOI: 10.12659/MSM.943732  

Most Viewed Current Articles

16 May 2023 : Clinical Research  

Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...

DOI :10.12659/MSM.940387

Med Sci Monit 2023; 29:e940387

0:00

17 Jan 2024 : Review article  

Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron Variant

DOI :10.12659/MSM.942799

Med Sci Monit 2024; 30:e942799

0:00

14 Dec 2022 : Clinical Research  

Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase Levels

DOI :10.12659/MSM.937990

Med Sci Monit 2022; 28:e937990

0:00

01 Jan 2022 : Editorial  

Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...

DOI :10.12659/MSM.935952

Med Sci Monit 2022; 28:e935952

0:00

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750